MRNA

Moderna Stock Analysis

AI Rating

Low
  • Quality3/10
  • Growth↑ 6/10
  • Value↓ 0/10
Moderna sales and earnings growth
MRNA Growth
Good
  • Revenue Y/Y↓ -39.93%
  • EPS Y/Y↑ 21.77%
  • FCF Y/Y↑ 48.83%
Moderna gross and profit margin trends
MRNA Profitability
Low
  • Gross margin ↑ 55.30%
  • EPS margin↓ -145.20%
  • ROIC 5Y↓ -19.71%
Moderna net debt vs free cash flow
MRNA Risk
Great
  • Debt / Equity↓ 0.1
  • Debt / FCF↓ 0.0
  • Interest coverage↑ 999.0

Moderna stock volatility is in-line with the overall market. We give it a Great risk rating.

More Biotechnology stocks ↗